Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With JEB (HOLOGENE17)

NCT03490331 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped No patient ongoing (none completed the study). Changes to the viral vector ongoing.

Conditions

Interventions

Sponsor

Holostem s.r.l.

Collaborators